Health News Releases

  • Today August 28
September 15, 2020 11:12
Phase II trial results demonstrated improvement in cognition with BI 425809 in adult patients with schizophrenia
Boehringer Ingelheim today announced the results from a 12-week, placebo-controlled Phase II trial, that demonstrated BI 425809 has met its primary endpoint. The data showed improvement in cognition i
September 14, 2020 11:11
Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia
Boehringer Ingelheim and Click Therapeutics today announced they have entered into a collaboration for the development and commercialization of a prescription-based digital therapeutic. It will utiliz
September 11, 2020 15:00
Vault Creation to Launch Eco-friendly Polymer Filter Mask ‘Vo Guard’ on Kickstarter at the End of September
Vault Creation Co., Ltd, a company with unrivalled micro-etching technology, will start funding for Vo Guard, a respiratory protection guard with eco-friendly polymer filters, at the end of September
September 11, 2020 08:46
Boehringer Ingelheim Advances Novel Bi-specific TRAILR2/CDH17 Antibody to Phase 1 Clinical Trial for Patients Living with Gastrointestinal Cancers
Boehringer Ingelheim today announced the advancement of the bi-specific and tetravalent therapeutic antibody, BI 905711, to its first-in-human clinical trial for patients with advanced gastrointestina
September 10, 2020 18:00
Takeda Announces Results from Phase 3 Clinical Trial Evaluating NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced results from the Phase 3 TOURMALINE-MM2 trial evaluating the addition of NINLARO™ (ixazomib) to lenalidomide and de
September 10, 2020 13:30
Takeda Divests Select Non-Core Assets in Europe to Cheplapharm for Approximately $562 million USD
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select non-core prescription pharmaceutical products
September 09, 2020 11:45
Pandemic Spotlights the Urgent Need for a National Patient Safety Board
Today, the Patient Safety Movement Foundation released a detailed white paper and its leadership issued the following statement urging the creation of a National Patient Safety Board: “COVID-19 has
September 09, 2020 11:25
Invivoscribe Appoints Loui Madakamutil to Lead Its Therapeutics Division as Chief Scientific Officer
Invivoscribe, Inc., an industry pioneer in developing and commercializing diagnostic products and reagents for hematological malignancies, announced today key members of the leadership team hired to d
September 03, 2020 17:50
SpeeDx and Nepean Hospital Awarded Federal Funding for Viral Respiratory Biomarker Test
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, in partnership with researchers from Nepean Blue Mountains Local Health District’s (NBMLHD) Nepean Hospital Intensive Care U
September 03, 2020 10:00
Private Group RLS (USA) Inc. Acquires GE Healthcare’s U.S. Radiopharmacy Network
RLS (USA) Inc., (Radioisotope Life Sciences) has purchased General Electric’s (GE) U.S. radiopharmacy network, making it the largest pure molecular imaging focused firm in the United States. Capitor,
September 02, 2020 16:00
ResMed Debuts AirTouch N20 Foam CPAP Mask, Its Softest Nasal Mask Ever
ResMed (NYSE: RMD, ASX: RMD) announced today the launch of its AirTouch N20 nasal mask, the company’s first CPAP nasal mask with a memory foam cushion and softest nasal mask ever. AirTouch N20 uses
September 02, 2020 11:30
Covetrus Appoints Jamey Seely General Counsel
Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announces the appointment of Jamey Seely as general counsel and corporate secretary, reporting to Dustin Finer, chief
September 01, 2020 17:35
Worldwide Esports Phenomenon and Ambassador Jake Lyon to Host Unite For Safe Care Virtual Event on September 17
Today, the Patient Safety Movement Foundation announced former professional Overwatch player and esports ambassador Jake Lyon will host the Foundation’s Unite For Safe Care Virtual Event. The event wi
September 01, 2020 16:37
Vifor Pharma Appoints Gregory Oakes as President North America and Member of the Executive Committee
Regulatory News: Vifor Pharma today announced the appointment of Gregory Oakes as EVP, President North America and member of the Vifor Pharma Executive Committee as of September 1, 2020. Gregory
August 31, 2020 09:07
Empagliflozin reduced the combined relative risk of cardiovascular death and hospitalization for heart failure by 25 percent in adults with and without diabetes who had heart failure with reduced ejection fraction
Full results from the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with and without diabetes, showed that empagliflozin was associated with a significan
August 26, 2020 17:45
Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint Reducing Seizure Frequency in Children with Dravet Syndrome or Lennox-Gastaut Syndrome
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) and Ovid Therapeutics Inc. (NASDAQ: OVID) (“Ovid”), a biopharmaceutical company committed to developing medicines that transform th
August 26, 2020 14:00
Pop Icon Belinda Carlisle To Perform At Unite For Safe Care Virtual Event on September 17
Today, the Patient Safety Movement Foundation announced Grammy-nominated global pop icon and Go-Gos frontwoman Belinda Carlisle will perform at the Foundation’s Unite For Safe Care Virtual Event. The
August 26, 2020 11:40
Nanox Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
NANO-X IMAGING LTD (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today the closing of its initial public offering of 10,555,556 ordinary shares, which include
August 25, 2020 17:35
Nanox Announces Pricing of Upsized Initial Public Offering
NANO-X IMAGING LTD (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today the pricing of its initial public offering of 9,178,744 ordinary shares at a price to t
August 25, 2020 11:20
Kohlberg and Mubadala Sign a Definitive Agreement to Acquire Majority Stake in PCI Pharma Services
PCI Pharma Services (“PCI” or “the Company”), a leading pharmaceutical and biopharmaceutical global supply chain solutions provider, and portfolio company of Partners Group, announced today the signin
August 21, 2020 14:30
Terns Pharmaceuticals to Present Data on Multiple NASH Programs at The Digital International Liver Congress™ 2020
Terns Pharmaceuticals, Inc., a biopharmaceutical company focused on developing best-in-class, single-agent and combination therapies to treat liver disease, announced today three poster presentations
August 20, 2020 10:00
New Studies Investigate the Accuracy of Noninvasive, Continuous Hemoglobin Monitoring with Masimo SpHb® on Neonates
Masimo (NASDAQ: MASI) today announced that in a study recently published in the Journal of Tropical Pediatrics, researchers evaluating Masimo SpHb® (noninvasive, continuous hemoglobin monitoring) on n
August 18, 2020 15:44
Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats
CARE (Corona Accelerated R&D in Europe) a new consortium supported by the Innovative Medicines Initiative (IMI) public-private partnership announced its launch today to accelerate the discovery and de
August 18, 2020 14:00
The Health Bank to Partner with Nanotronics Health, LLC, to Distribute Low-Cost, US-Manufactured Non-Invasive Ventilator for Respiratory Support During COVID-19 Pandemic
Salman Arif, the CEO of The Health Bank (THB) Global, announced today that the company is partnering with Nanotronics Health, LLC, to distribute nHaleTM, a non-invasive ventilator. It will be distribu
August 18, 2020 13:05
LG Chem Life Sciences and TransThera Biosciences Announce License Agreement for Potential Treatment of NASH and Other Chronic Inflammatory Conditions
LG Chem Life Sciences (“LG Chem”), a division of LG Chem, and TransThera Biosciences Co. Ltd. (“TransThera”), a clinical-stage biotechnology company based in Nanjing, China, announced today that LG Ch
25 per page50 per page75 per page100 per page